ACADIA Pharmaceuticals (ACAD) Sees Early Action on Partner Deal
Tweet Send to a FriendGet Alerts ACAD Hot Sheet
Trade ACAD Now!
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) is on the move early Wednesday which could be related to Allergan, Inc. (NYSE: AGN) deal to acquire MAP Pharmaceuticals, Inc. (NASDAQ: MAPP) for $25 per share, or a 60% premium.
Like MAPP, ACADIA is in a collaboration with Allergan.
Shares last traded at $5.96, up 5%.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Like MAPP, ACADIA is in a collaboration with Allergan.
Shares last traded at $5.96, up 5%.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: ViroPharma (VPHM) on the Move Following Takeover Chatter - Reuters
- UPDATE: Liberty Global (LBTYA) Interested in Kabel Deutschland - FT
- BlackBerry (BBRY) Deal 'Safe' Following Nokia (NOK) Chatter
Create E-mail Alert Related Categories
Rumors, Trader Talk
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
